(a) Time schedule of transposon-mediated reprogramming. EFM, embryonic fibroblast medium; F15L, serum-based ESC medium; K15L, serum-free ESC medium. Triangles, medium change. (b) Alkaline phosphatase staining of day 14 colonies. ‘−’, a negative control transfection using an eGFP expression vector. (c) Enlarged view of AP-stained colonies with (bottom) and without (top) VPA treatment. (d) Immunostaining of Nanog at day 14 with (bottom) and without (top) VPA treatment. Left, phase contrast; right, anti-Nanog immunostaining. (e) The numbers of colonies obtained by transposon-based reprogramming. OSKM* is identical to OSKM except that Sox2 and Klf4 are linked by F2A instead of T2A. (f) Transposon copy number distribution depending on the transposon plasmid amount. The OSKM* vector was used for the 2.0 μg and the 0.50 μg transfection, and the OSKML vector for the 0.25 μg transfection. *** Only one single-copy transposon iPS colony was identified in the experiments. Data are shown as mean ± s.d. Experiments were performed at least 3 times per each condition. **, p<0.05 (Student's t test). Scale bars, 5 mm (b), 100 μm (c, d)